Clinical Trial Update: REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

View source ↗

Summary

Clinical trial update describing resorbable scaffolds that elute everolimus to treat infrapopliteal artery disease in patients with chronic limb-threatening isc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-threatening Ischemia

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Cardiovascular and Interventional Radiological Society of Europe | Conditions: Chronic Limb Threatening Ischemia, Chronic Limb-Threatening Ischemia | Status: NOT_YET_RECRUITING